Today's Research Daily features new research reports on 16 major stocks, including The Charles Schwab Corporation (SCHW), ...

Gilead Sciences has announced the European Medicines Agency’s (EMA) validation for a parallel accelerated review of ...

DelveInsight's Advanced Therapy Medicinal Products Market Insights report provides the current and forecast market analysis, ...

Three bovine veterinarians had undetected H5N1 avian influenza infections despite no apparent contact with infected cows, ...

Investing.com -- Morgan Stanley expects the FDA to approve Gilead Sciences (NASDAQ: GILD )' Lenacapavir (LEN) for HIV ...

A groundbreaking injectable designed to curb the global spread of HIV is now at risk of being delayed due to Donald Trump's ...

Wrestling sectionals were held over the weekend and Marion-area competitors earned berths into the upcoming district ...

Ligand originated, structured, and invested $50 million and led a syndicate of co-investors who invested $25 million in ...

In a landmark event held yesterday at its headquarters in Ikeja, Lagos, Africa’s first Pan-African social media network, ...

A new clinical trial from Scripps Research in La Jolla aims to make significant gains in the global fight against malaria by making a drug that has been around since the 1970s last longer. Working ...

The winner plays for the championship Saturday at 4:30 p.m. at Mount Vernon Nazarene against either No. 4 Fairbanks or No. 5 ...